Bora CDMO Bora CDMO

X

Find Rabeximod manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Rabeximod
Also known as: Rob 803, 872178-65-9, Rabeximod [inn], Rob-803, J4d3k58w3z, Rabeximodum
Molecular Formula
C22H24ClN5O
Molecular Weight
409.9  g/mol
InChI Key
PDNNUMNEXITLCZ-UHFFFAOYSA-N
FDA UNII
J4D3K58W3Z

Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.
1 2D Structure

Rabeximod

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(9-chloro-2,3-dimethylindolo[3,2-b]quinoxalin-6-yl)-N-[2-(dimethylamino)ethyl]acetamide
2.1.2 InChI
InChI=1S/C22H24ClN5O/c1-13-9-17-18(10-14(13)2)26-22-21(25-17)16-11-15(23)5-6-19(16)28(22)12-20(29)24-7-8-27(3)4/h5-6,9-11H,7-8,12H2,1-4H3,(H,24,29)
2.1.3 InChI Key
PDNNUMNEXITLCZ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC2=C(C=C1C)N=C3C(=N2)C4=C(N3CC(=O)NCCN(C)C)C=CC(=C4)Cl
2.2 Other Identifiers
2.2.1 UNII
J4D3K58W3Z
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Rob 803

2. 872178-65-9

3. Rabeximod [inn]

4. Rob-803

5. J4d3k58w3z

6. Rabeximodum

7. Rabeximodum [inn]

8. Unii-j4d3k58w3z

9. Rob803

10. Gtpl9856

11. Schembl16053849

12. Dtxsid701007428

13. Db05772

14. Sb18674

15. Q27281185

16. 2-(9-chloro-2,3-dimethylindolo[3,2-b]quinoxalin-6-yl)-n-[2-(dimethylamino)ethyl]acetamide

17. 2-(9-chloro-2,3-dimethyl-6h-indolo[2,3-b]quinoxalin-6-yl)-n-[2-(dimethylamino)ethyl]ethanimidic Acid

18. 6h-indolo(2,3-b)quinoxaline-6-acetamide, 9-chloro-n-(2-(dimethylamino)ethyl)-2,3-dimethyl-

2.4 Create Date
2012-03-21
3 Chemical and Physical Properties
Molecular Weight 409.9 g/mol
Molecular Formula C22H24ClN5O
XLogP33.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Exact Mass409.1669381 g/mol
Monoisotopic Mass409.1669381 g/mol
Topological Polar Surface Area63 Ų
Heavy Atom Count29
Formal Charge0
Complexity590
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in rheumatoid arthritis.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Rob 803 is an immunomodulator.


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY